All American boys will be vaccinated against human papillomavirus (HPV)
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
The Council of the US Centers for Disease Control and Prevention (CDC) concluded that all boys need a vaccination against human papillomavirus (HPV). Currently, only vaccinated girls are vaccinated to prevent cervical cancer. Boys spend it at will.
With 13 votes in favor, with one abstention, the council representatives voted that all American children under the age of 11 should be vaccinated against HPV. Such large-scale immunization, according to experts, will primarily be an additional protection for women from cervical cancer. In addition, it will protect boys from human-associated papilloma of cancer, such as cancer of the penis or throat.
The decision of the Board of the US Centers for Disease Control and Prevention will come into effect after approval by CDC Director Thomas Freiden and US Health and Social Care Minister Kathleen Sebelius.
As previous studies have shown, at present, about 50% of adult men in the world are infected with the human papillomavirus, which is sexually transmitted. This virus causes 70% of cases of cervical cancer, as well as about 60% of cancers of the oral cavity and pharynx.
Currently, the market has two vaccines against the human papillomavirus - Gardasil company Merck and Cervarix manufactured by GlaxoSmithKline. These vaccines protect against the most oncogenic strains of the virus - 16 and 18, and also contain antigens of other common strains. Thanks to this, each of the vaccines provides more than 90% prevention of papillomavirus infection.
[